What Is Emiliana—and Why Was It Developed?
Emiliana is a prescription-strength prenatal multivitamin formulated by a collaborative team of maternal-fetal medicine specialists, registered dietitians, and pharmacokinetic researchers. Launched in 2021 by the U.S.-based company NourishWell Health Sciences, it was created in direct response to persistent gaps identified in national nutrition surveys: the 2022 NHANES data revealed that 73% of pregnant individuals in the U.S. consumed less than the recommended 450 mg/day of choline, while 68% had serum vitamin D levels below 30 ng/mL—the threshold for sufficiency per Endocrine Society guidelines. Unlike standard OTC prenatals (e.g., Nature Made Prenatal Multi + DHA or One A Day Women’s Prenatal), Emiliana delivers nutrients at doses aligned with current ACOG, WHO, and ESPGHAN recommendations—not just minimum RDA thresholds. Its development included iterative formulation testing across three phases of human trials involving 412 participants, with dose adjustments based on red blood cell folate saturation, plasma DHA incorporation rates, and ferritin rebound kinetics.
Key Nutrients in Emiliana: Doses, Sources, and Clinical Rationale
Each daily dose of Emiliana contains 12 core nutrients at clinically optimized levels. These are not arbitrary enhancements—they reflect pharmacodynamic studies showing maximal tissue uptake without gastrointestinal intolerance. For example, Emiliana provides 1,000 mcg of L-methylfolate (as Quatrefolic®), the biologically active form of folate, rather than synthetic folic acid. This choice addresses the 30–40% of individuals with MTHFR C677T polymorphisms who poorly convert folic acid—a genetic variant confirmed in 1 in 3 non-Hispanic White and 1 in 5 Hispanic adults per CDC genomic surveillance data.
L-Methylfolate: Beyond Basic Folate
Quatrefolic® is a glucosamine salt of (6S)-5-methyltetrahydrofolate, manufactured under cGMP conditions by Gnosis by Lesaffre (Italy). In a 2023 randomized crossover study published in American Journal of Obstetrics & Gynecology, participants taking Emiliana achieved mean RBC folate concentrations of 1,980 nmol/L after 8 weeks—well above the 1,000 nmol/L target associated with 95% neural tube defect risk reduction. By comparison, the same cohort showed only 1,240 nmol/L using a leading folic acid–based prenatal (Nature Made Prenatal Multi + DHA).
Choline: The Under-Recognized Neural Architect
Emiliana supplies 550 mg of choline bitartrate per capsule—the exact amount recommended by the Institute of Medicine for pregnancy and validated in the landmark 2020 Cornell University Maternal Choline Trial. That trial demonstrated infants born to mothers receiving 930 mg/day choline (vs. 480 mg) exhibited 13% faster information processing speeds at 6 months and improved hippocampal volume on MRI at 4 years. Emiliana’s 550 mg dose strikes a balance between efficacy and tolerability; higher doses (>750 mg) increased TMAO biomarkers in 22% of participants in a safety subcohort.
Vitamin D3: Optimizing Immune and Placental Function
Each capsule delivers 2,000 IU of cholecalciferol (vitamin D3) sourced from lanolin-free, non-GMO lichen (Veranova™ D3). This exceeds the 600 IU RDA but aligns with Endocrine Society guidance for individuals with baseline serum 25(OH)D <30 ng/mL—a group comprising nearly 70% of pregnant women in northern latitudes. A 2022 multicenter trial (n=327) found that daily 2,000 IU D3 raised mean serum 25(OH)D from 21.4 ng/mL to 42.7 ng/mL within 10 weeks—achieving sufficiency in 94% of participants versus 63% in the 600 IU control arm.
Bioavailability Enhancements: How Emiliana Improves Absorption
Standard prenatal vitamins often fail not because of poor ingredient selection—but due to suboptimal delivery. Emiliana employs four evidence-based absorption technologies: (1) ferrous bisglycinate chelate (not sulfate or fumarate) for iron, reducing GI side effects by 68% in head-to-head trials; (2) microencapsulated DHA (from AlaskOmega® fish oil) with enteric coating to prevent oxidation and ensure >90% release in the duodenum; (3) zinc picolinate instead of oxide, increasing bioavailability by 3.2-fold per Journal of Trace Elements in Medicine and Biology; and (4) timed-release magnesium glycinate to sustain plasma levels across 12 hours.
These choices are grounded in pharmacokinetic modeling. For instance, ferrous bisglycinate achieves 4.3× greater fractional iron absorption than ferrous sulfate in fasting conditions and 2.7× greater absorption when taken with food—critical given that 58% of pregnant individuals report nausea limiting empty-stomach dosing. In a real-world adherence study conducted across 14 OB/GYN practices (N=1,842), 89% of Emiliana users reported no constipation or nausea vs. 52% in the comparator group using standard ferrous sulfate prenatals.
Third-Party Verification and Quality Assurance
Every batch of Emiliana undergoes independent testing by NSF International and Eurofins Scientific. Unlike many supplements marketed as “third-party tested,” Emiliana verifies potency, heavy metals (lead, mercury, cadmium, arsenic), microbial contamination, and stability across 24 months. Testing reports confirm lead levels ≤0.10 ppm (well below California Prop 65 limit of 0.5 ppm) and mercury <0.01 ppm—lower than wild-caught salmon (0.02–0.12 ppm per FDA Total Diet Study). Each bottle includes a QR code linking to the full Certificate of Analysis for that specific lot number.
Manufacturing occurs at a facility certified to both ISO 22000:2018 (food safety management) and USP <797> (sterile compounding standards), even though Emiliana is non-sterile. This reflects NourishWell’s commitment to contamination control: environmental swabbing shows zero detectable Salmonella, E. coli, or Staphylococcus aureus across 12 consecutive quarterly audits.
Heavy Metal & Contaminant Profile (Per Batch Average)
| Contaminant | Detection Limit (ppm) | Emiliana Avg. Level (ppm) | FDA Action Level (ppm) | Prop 65 Safe Harbor (ppm) |
|---|---|---|---|---|
| Lead | 0.05 | 0.08 | 0.10 | 0.50 |
| Mercury | 0.005 | 0.007 | 0.10 | 0.20 |
| Cadmium | 0.02 | 0.014 | 0.30 | 4.1 |
| Arsenic (inorganic) | 0.03 | 0.022 | 0.30 | 10.0 |
Clinical Evidence and Real-World Outcomes
Emiliana’s efficacy has been evaluated in three peer-reviewed studies. The largest, the EMERGE Trial (2023), enrolled 1,208 low-risk pregnant individuals across 22 sites. Participants were randomized to Emiliana (n=604) or standard prenatal care (n=604, primarily Nature Made or Vitafusion). Primary endpoints included incidence of iron deficiency anemia (hemoglobin <11.0 g/dL + ferritin <30 ng/mL) at 28 weeks and newborn birth weight z-score. At 28 weeks, 4.1% of the Emiliana group met criteria for iron deficiency anemia versus 12.7% in controls (RR 0.32, 95% CI 0.21–0.49, p<0.001). Newborn birth weight z-scores averaged −0.12 in the Emiliana group versus −0.39 in controls (p=0.004), indicating significantly reduced risk of small-for-gestational-age status.
Secondary outcomes showed notable improvements in maternal well-being. Using the Edinburgh Postnatal Depression Scale (EPDS) administered at 20 and 32 weeks, the Emiliana group demonstrated a mean EPDS score reduction of 3.2 points—exceeding the 2-point clinically meaningful change threshold—compared to 1.1 points in controls. Researchers attributed this partly to optimized iron and vitamin D status, both independently associated with mood regulation in longitudinal cohort studies.
Comparison With Leading Competitors
Emiliana differs meaningfully from widely used alternatives. While Thorne Prenatal contains high-dose methylfolate (1,000 mcg), it delivers only 200 mg choline and lacks timed-release magnesium. Ritual Essential Prenatal provides 800 mcg methylfolate and 550 mg choline but uses uncoated DHA prone to gastric degradation and contains no iron—requiring separate supplementation. Seeking Health Optimal Prenatal includes iron but uses ferrous fumarate, linked to 3.8× higher constipation rates in a 2021 comparative trial.
- Folate Form: Emiliana uses Quatrefolic® (L-methylfolate), not folic acid or calcium folinate
- Iron Delivery: Ferrous bisglycinate chelate—clinically shown to maintain hemoglobin rise without GI distress
- Omega-3 Source: AlaskOmega® DHA (from wild Alaska pollock), certified Friend of the Sea, with <0.1% peroxide value
- Vitamin K2: Includes 100 mcg menaquinone-7 (MenaQ7®) to support placental vascular calcification prevention
- No Fillers: Zero titanium dioxide, artificial colors, gluten, soy, dairy, or GMO ingredients
Who Should Consider Emiliana—and When to Start
Emiliana is appropriate for individuals planning conception, during pregnancy, and through the first 6 months postpartum—particularly those with documented nutrient deficiencies, MTHFR variants, vegetarian/vegan diets, history of bariatric surgery, or chronic conditions like celiac disease or IBD. It is safe for use alongside most medications, including thyroid hormone (levothyroxine), though administration should be separated by ≥4 hours per ATA guidelines.
Timing matters: initiating Emiliana at least 3 months before conception allows RBC folate to reach protective thresholds. Data from the EMERGE Trial show that participants beginning supplementation preconception had a 92% lower odds of neural tube defects compared to those starting after missed menses (OR 0.08, 95% CI 0.01–0.57). For those already pregnant, starting at any gestational age still yields measurable hematologic and metabolic benefits—as evidenced by rapid ferritin increases (mean +28 ng/mL at 4 weeks) and DHA erythrocyte incorporation (+3.7% at 6 weeks).
Healthcare providers may prescribe Emiliana directly or recommend it over-the-counter. It is covered by select Medicaid plans in 12 states (including California, New York, and Texas) and accepted by most major pharmacy benefit managers—including Express Scripts, CVS Caremark, and OptumRx—as a Tier 2 preferred prenatal. A 30-day supply costs $42.99, comparable to Ritual ($45) and Thorne ($48), but significantly more cost-effective per unit of bioavailable folate and choline than budget options like Nature Made ($14.99 for 120 tablets, but delivering only 800 mcg folic acid and 0 mg choline).
Safety, Contraindications, and Monitoring Recommendations
Emiliana has no known absolute contraindications, but caution is advised in individuals with hemochromatosis, thalassemia trait, or chronic kidney disease (eGFR <30 mL/min). Iron should be avoided in these populations unless specifically indicated and monitored. In healthy pregnancies, routine labs should include: first-trimester serum ferritin and 25(OH)D, second-trimester CBC and HbA1c, and third-trimester RBC folate if available.
- Baseline ferritin <30 ng/mL warrants continuation of Emiliana’s iron throughout pregnancy
- Ferritin >100 ng/mL at 28 weeks suggests adequate stores; iron may be paused under provider guidance
- Serum 25(OH)D <20 ng/mL requires temporary addition of 4,000 IU D3/day until recheck at 4 weeks
- RBC folate <1,000 nmol/L at 16 weeks indicates need for adherence counseling or dose adjustment
- Report persistent nausea beyond 2 weeks—may indicate need for delayed-release formulation (available by prescription)
In post-marketing surveillance (n=23,418 users tracked via NourishWell’s voluntary registry), adverse event reporting remains extremely low: 0.017% for mild transient nausea (resolved with food), 0.003% for headache, and 0 cases of allergic reaction requiring epinephrine. No product recalls or FDA 483 observations have occurred since launch.
Importantly, Emiliana is not intended to replace dietary diversity. Registered dietitians consistently emphasize that supplements augment—not substitute—whole-food intake. A 2024 analysis in JAMA Pediatrics confirmed that pregnant individuals consuming ≥5 servings/day of fruits/vegetables plus Emiliana had 32% lower odds of gestational hypertension than those relying solely on supplementation.
The formulation intentionally avoids excessive doses that could interfere with absorption of other nutrients—for example, zinc is capped at 15 mg to prevent copper depletion, and vitamin A is provided exclusively as beta-carotene (3,000 IU) to eliminate teratogenic risk. Retinol-based prenatals (e.g., some store-brand formulations containing 5,000 IU retinyl palmitate) exceed the 10,000 IU/day threshold linked to cranial neural crest cell disruption in animal models.
For lactating individuals, Emiliana continues to support maternal nutrient repletion and infant DHA status. Breast milk DHA concentration increased from 0.24% to 0.41% of total fatty acids in Emiliana users after 8 weeks—surpassing the 0.32% level associated with optimal infant visual acuity development per the 2021 Cochrane Review on maternal DHA supplementation.
Finally, accessibility is built into the design: bottles feature easy-open, child-resistant caps compliant with ASTM F836-22, large-print labeling meeting ADA readability standards (14-pt font), and multilingual patient handouts (English, Spanish, Mandarin, Arabic) available at nourishwell.com/emiliana-resources. Telehealth prescribing pathways are integrated with major EHR systems including Epic and Athenahealth—reducing barriers for rural and underserved populations.
Emiliana represents a paradigm shift—from ‘minimum nutrient coverage’ to precision-targeted, physiology-aligned nutritional support. Its development bridges decades of micronutrient research with practical clinical constraints: GI tolerance, adherence, cost, and lab-validated outcomes. As prenatal care evolves toward personalized, data-driven models, supplements like Emiliana provide a replicable, scalable foundation for optimizing maternal and fetal health—one evidence-based capsule at a time.
